Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.86
+0.00 (0.00%)
AAPL  260.58
+0.00 (0.00%)
AMD  203.37
+0.00 (0.00%)
BAC  52.77
+0.00 (0.00%)
GOOG  303.56
+0.00 (0.00%)
META  644.78
+0.00 (0.00%)
MSFT  398.46
+0.00 (0.00%)
NVDA  187.90
+0.00 (0.00%)
ORCL  156.54
+0.00 (0.00%)
TSLA  411.71
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.